E
Edward Cox
Researcher at Food and Drug Administration
Publications - 8
Citations - 3463
Edward Cox is an academic researcher from Food and Drug Administration. The author has contributed to research in topics: Antibiotic resistance & Public health. The author has an hindex of 5, co-authored 8 publications receiving 1960 citations.
Papers
More filters
Journal ArticleDOI
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
Evelina Tacconelli,Elena Carrara,Alessia Savoldi,Stéphan Juergen Harbarth,Marc Mendelson,Dominique L Monnet,Céline Pulcini,Gunnar Kahlmeter,Jan Kluytmans,Yehuda Carmeli,Marc Ouellette,Kevin Outterson,Jean B. Patel,Marco Cavaleri,Edward Cox,Christopher R. Houchens,M Lindsay Grayson,Paul Hansen,Nalini Singh,Ursula Theuretzbacher,Nicola Magrini,Aaron O. Aboderin,Seif Al-Abri,Nordiah Awang Jalil,Nur Benzonana,Sanjay Bhattacharya,Adrian Brink,Francesco Robert Burkert,Otto Cars,Giuseppe Cornaglia,Oliver J. Dyar,Alexander W. Friedrich,Ana Cristina Gales,Sumanth Gandra,Christian G. Giske,Debra A. Goff,Herman Goossens,Thomas Gottlieb,Manuel Guzman Blanco,Waleria Hryniewicz,Deepthi Kattula,Timothy Jinks,Souha S. Kanj,Lawrence Kerr,Marie-Paule Kieny,Yang Soo Kim,Roman S. Kozlov,Jaime Labarca,Ramanan Laxminarayan,Karin Leder,Leonard Leibovici,Gabriel Levy-Hara,Jasper Littman,Surbhi Malhotra-Kumar,Vikas Manchanda,Lorenzo Moja,Babacar Ndoye,Angelo Pan,David L. Paterson,Mical Paul,Haibo Qiu,Pilar Ramon-Pardo,Jesús Rodríguez-Baño,Maurizio Sanguinetti,Sharmila Sengupta,Mike Sharland,Massinissa Si-Mehand,Lynn L. Silver,Wonkeung Song,Martin Steinbakk,Jens Thomsen,Guy E. Thwaites,Jos W. M. van der Meer,Nguyen Van Kinh,Silvio Vega,Maria Virginia Villegas,Agnes Wechsler-Fördös,Heiman F. L. Wertheim,Evelyn Wesangula,Neil Woodford,Fidan O Yilmaz,Anna Zorzet +81 more
TL;DR: Future development strategies should focus on antibiotics that are active against multidrug-resistant tuberculosis and Gram-negative bacteria, and include antibiotic-resistant bacteria responsible for community-acquired infections.
Journal ArticleDOI
The Emergency Use Authorization of Peramivir for Treatment of 2009 H1N1 Influenza
Debra Birnkrant,Edward Cox +1 more
TL;DR: On October 23 the FDA issued an Emergency Use Authorization for peramivir for the treatment of suspected or confirmed cases of 2009 H1N1 influenza and Drs.
Journal ArticleDOI
Combating Emerging Threats — Accelerating the Availability of Medical Therapies
TL;DR: A new paradigm for accelerating evaluation of investigational therapies during public health emergencies caused by emerging infectious diseases could permit therapies shown to be safe and effective to reach patients as soon as possible.
Journal ArticleDOI
Needed: Antimicrobial Development.
TL;DR: Clinicians are now encountering infections that are susceptible to few or few infections, with low survival rates, according to a large number of patients diagnosed with bacterial infections.
Journal ArticleDOI
Ketek — The FDA Perspective
TL;DR: In response to the article by Ross in this issue of the Journal, the Food and Drug Administration (FDA) reviewed Ketek (telithromycin).